Pharmaceutical Industry Information Portal

HomeNews

News

FDA approves Agios’ mitapivat as first disease-modifying therapy for genetic blood disorder

Agios Pharmaceuticals, Inc., a leader in the field of cellular metabolism pioneering therapies for genetically defined diseases, announced that the U.S. Food and Drug...

Hurry up to book a stand at the business event “Ingredients and Additives” 2022!

Take part in the international conference and exhibition "Ingredients and Additives".In 2022, the event will take place on the territory of Technopark Skolkovo innovation...

Pharmasyntez starts construction of new parenteral nutrition plant in Ussuriysk

The Pharmasyntez Group of companies is going to launch the parenteral (intravenous) nutrition department in Primorye. At a meeting with Oleg Kozhemyako, Governor of Primorsky...

The European Medicines Agency has published key information on human and veterinary medicines for 2021

The overview of key recommendations in 2021 includes figures on the authorisation of medicines and a selection of new treatments, as well as  safety...

Takeda and Resilience enter development deal for plasma meds

The Takeda Pharmaceutical Co-led group that is developing a blood plasma treatment for COVID-19 has started manufacturing while the late-stage trial to determine whether...

Rovi seals 10-year Moderna deal extension to manufacture mRNA drugs

Long-term agreement includes a series of investments to acquire new equipment and adapt the present ROVI drug product fill-finish facilities and production lines in...
spot_img

Expert Articles

spot_img